Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
2.
Environ Monit Assess ; 193(9): 560, 2021 Aug 11.
Article in English | MEDLINE | ID: mdl-34379192

ABSTRACT

Mining activities in Canada's pristine Arctic (e.g., driving on unpacked roads, blasts, rock grinding, diesel combustion, and garbage incineration) could add local sources of airborne fine particulate matter with a diameter of < 2.5 µm (PM2.5) to their surrounding area. The increase in PM2.5 above the background level around a mine represents a potential disturbance to caribou. To quantify the spatial distribution of the elevated PM2.5, we investigated three different sampling schemes to measure PM2.5 concentration using a portable monitor. We found that the best sampling scheme was to use the regional background PM2.5 as the reference and analyze the anomaly of PM2.5 measured at sites around the mine complex from the background level. The regional background PM2.5 values were measured at the Daring Lake Tundra Research Station during 2018 and 2019. Our results indicated that the background PM2.5 was not a low and constant value but varied with rain events, wind direction, and the impacts of forest fire smoke. After excluding periods affected by forest fires smokes, we found the background PM2.5 was close to 0 µg m-3 for the first few hours after rain, and then increased logistically with the time after rain (tar) to the maximum of 5 (or 10) µg m-3 when the wind came from the north (or south) of the NW-SE axis. The NW-SE axis in western Canada divides the tundra north with few anthropogenic PM2.5 sources from the forested south with many PM2.5 sources from forest fire smokes and human activities. Analyses of PM2.5 anomaly from the background (i.e., PM2.5 measured at a site around the mining complex-the background level at the corresponding tar and wind direction) revealed that the zone of elevated PM2.5 around the mine (Zepm) expanded with tar. In the first few hours after rain, PM2.5 was close to 0 everywhere except within meters of a source (e.g., a truck exhaust) in the downwind direction. During tar = 6 to 96 h, Zepm expanded to 6.3 km in the downwind direction when the wind came from south of the NW-SE axis. A similar result was found in the downwind direction when the wind came from north of the NW-SE axis, with Zepm = 4.4 km. In the upwind direction, the value of Zepm was much smaller, being 0.7 km (or 1.0 km) when the wind came from the north (or south) of the NW-SE axis. For the period of tar between 96 and 192 hours, Zepm further expanded to 21.2 km when the wind from the south of the NW-SE axis. The results from this study indicated that this reference paradigm that uses the regional background PM2.5 as the reference in combination with a portable PM2.5 monitor worked well for quantifying the tempo-spatial patterns of PM2.5 at locations in remote and mostly pristine Arctic. However, their effectiveness for other regions needs further investigation.


Subject(s)
Air Pollutants , Air Pollutants/analysis , Environmental Monitoring , Humans , Motor Vehicles , Particulate Matter/analysis , Vehicle Emissions/analysis
3.
J Adolesc Young Adult Oncol ; 8(4): 463-468, 2019 08.
Article in English | MEDLINE | ID: mdl-30942651

ABSTRACT

Given that young women with breast cancer often have concerns and priorities attributable to their life stage, we conducted a series of interviews to better understanding the surgical decision-making experience among women diagnosed at age ≤40. Women spoke of how the potential effect of an extended recovery was affecting their decision and, in some cases, contributing to decisional conflict. Several women described their worry of leaving cancer cells behind; others cited the need for continued surveillance as a consideration. Attention to situational anxiety and concerns about recurrence are warranted to ensure that decisions are made in a supportive and patient-centered setting.


Subject(s)
Anxiety/psychology , Breast Neoplasms/psychology , Breast Neoplasms/surgery , Decision Making , Mastectomy/psychology , Neoplasm Recurrence, Local/psychology , Adult , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Female , Humans , Neoplasm Staging , Patient Participation , Postoperative Complications/psychology , Surveys and Questionnaires
4.
Pediatr Blood Cancer ; 66(1): e27445, 2019 01.
Article in English | MEDLINE | ID: mdl-30207072

ABSTRACT

BACKGROUND: Hereditary tumor predisposition syndromes (HTPSs) are being recognized more frequently in the etiology of pediatric cancer. Previous research indicates that disclosure of tumor susceptibility is a significant event in adolescents' lives. Insight into adolescents' adjustment to knowledge of their syndromes can guide healthcare delivery, particularly genetic counseling. This study explored the experiences of adolescents with hereditary tumor predisposition and their perceptions of living at risk. METHODS: Seven adolescents, ages 14 to 17, representing six different childhood-onset HTPSs, were purposively sampled and interviewed using a study-specific semistructured interview guide. We explored the disclosure process, support systems, and the perceived benefits and harms of knowledge of hereditary tumor susceptibility. Interview transcripts were analyzed via interpretive description. RESULTS: Three major themes emerged from the data: (1) The benefits of knowledge outweigh the harms; (2) context surrounding genetic testing must be recognized; and (3) self-concept is influenced but not defined by tumor risk. CONCLUSIONS: We conclude that adolescents recognize the challenges associated with awareness of tumor predisposition but may also identify positive aspects in their experiences, reflecting a changed life perspective. Results of this exploratory study suggest strategies that can guide pretest and posttest genetic counseling of adolescents for HTPSs, facilitating the adaptive incorporation of genetic information into an adolescent's self-concept.


Subject(s)
Genetic Counseling , Genetic Predisposition to Disease , Neoplastic Syndromes, Hereditary/genetics , Neoplastic Syndromes, Hereditary/psychology , Adolescent , Female , Follow-Up Studies , Genetic Testing , Humans , Male , Qualitative Research , Surveys and Questionnaires
5.
Psychooncology ; 27(12): 2802-2808, 2018 12.
Article in English | MEDLINE | ID: mdl-30242934

ABSTRACT

OBJECTIVE: This paper presents data on licensure/certification status, supervision of multidisciplinary pediatric psychosocial staff, and training opportunities in pediatric cancer programs in the United States, data that are critical to provide care aligned with the Standards of Psychosocial Care in Pediatric Cancer (Psychosocial Standards). METHODS: An online survey of psychosocial care consistent with the Psychosocial Standards was completed from a national sample of pediatric cancer programs (144/200). Licensure/certification status, availability and format of supervision for multidisciplinary staff (social workers, psychologists, psychiatrists, child life specialists/recreational therapists), and types and number of psychosocial trainees were reported. RESULTS: Nearly all pediatric psychosocial providers were licensed/certified. Peer consultation was the most frequently endorsed form of staff supervision although a sizeable group of centers reported no systematic ongoing supervision. Trainees in social work and child life were most common although the size of trainee cohorts is generally small. Psychosocial trainees are more prevalent in sites with pediatric hematology/oncology medical fellowship programs and in larger programs. CONCLUSIONS: A properly trained and supported psychosocial workforce is essential to providing evidence-based care consistent with the Psychosocial Standards. Psychosocial providers are appropriately licensed. However, supervision opportunities are variable and may be inadequate for the intensity of the work. It is important to address the limited opportunities for trainees in pediatric cancer programs, which may influence the pipeline for ongoing and future work in this area.


Subject(s)
Clinical Competence , Interprofessional Relations , Neoplasms/therapy , Psycho-Oncology/education , Psychology, Child/education , Social Work/education , Female , Humans , Male , Neoplasms/psychology , United States
6.
BMJ Open ; 8(8): e024064, 2018 08 08.
Article in English | MEDLINE | ID: mdl-30093523

ABSTRACT

INTRODUCTION: Patient-derived xenografts (PDXs) have the potential to transform personalised cancer care, however, little is known about the acceptability of using PDXs to guide treatment decision-making. Given that patient and community preferences can influence satisfaction with care as well as the success of new technologies, we will evaluate the acceptability of PDXs in individuals affected by cancer and community comparisons. METHODS AND ANALYSIS: This comparative cross-sectional study will recruit 323 individuals affected by cancer (cancer survivors (of childhood or adult cancer) and parents of childhood cancer survivors) and 323 community comparisons (adults and parents). We will collect data via structured interviews and questionnaires. To determine the acceptability of PDXs, we will assess five domains: willingness to use PDXs when/if diagnosed with cancer, perceived advantages and disadvantages of PDXs, maximum acceptable out-of-pocket costs per patient, maximum acceptable turnaround time to receive results and maximum acceptable number of mice sacrificed per patient. The primary endpoint will be participants' decisional balance ratio (calculated as participants' advantages ratings divided by perceived disadvantages ratings). ETHICS AND DISSEMINATION: The study protocol has been approved by the South Eastern Sydney Local Health District Human Research Ethics Committee (HREC:12/173) and UNSW Sydney (HC15773). The results will be disseminated in peer-reviewed journals and at scientific conferences. A lay summary will be published on the Behavioural Sciences Unit website.


Subject(s)
Heterografts/transplantation , Neoplasms/surgery , Patient Acceptance of Health Care/statistics & numerical data , Precision Medicine/methods , Adolescent , Adult , Animals , Australia , Cancer Survivors/psychology , Cancer Survivors/statistics & numerical data , Case-Control Studies , Child , Clinical Protocols , Cross-Sectional Studies , Female , Humans , Interviews as Topic , Male , Mice , New Zealand , Parents/psychology , Surveys and Questionnaires
7.
Psychooncology ; 27(7): 1825-1832, 2018 07.
Article in English | MEDLINE | ID: mdl-29645321

ABSTRACT

OBJECTIVES: Using a novel measure, examine maternal perceptions of the process by which issues pertaining to family communication of BRCA test results are addressed during cancer genetic counseling. METHODS: After receiving BRCA results, mothers (N = 211) of minor-age children reported on their counseling experiences with providers using a communication process measure as well as other psychosocial variables. RESULTS: The novel Genetic Counseling Communication Process measure demonstrated good internal consistency of its 2 factors: patient-led communication (Cronbach's α = 0.73) and provider-led communication (Cronbach's α = 0.82). Participants most often reported that discussions about family communication of BRCA test results to children and adult relatives were led only by their providers (38.2%-39.2%), as opposed to being led by the patient, both parties, or neither party. Providers were most likely to lead these discussions when mothers had stronger family histories of cancer and expressed more confidence about making a decision to talk to their children about BRCA. However, mothers typically led such discussions if they were raising older children and held more positive attitudes about pediatric BRCA testing. CONCLUSIONS: When the assessment of BRCA genetic counseling outcomes includes family communication to potentially at-risk relatives, we learned that most but not all sessions addressed this topic. Cancer family history, child age, and maternal attitudes are important co-factors in these patient-provider communication exchanges. Providers delivering BRCA genetic counseling should be attentive to mothers' information and support needs regarding communicating cancer genetic test results to at-risk relatives, including children.


Subject(s)
Breast Neoplasms/psychology , Disclosure , Genetic Counseling/psychology , Mother-Child Relations , Adolescent , Adult , Child , Decision Making , Female , Genetic Predisposition to Disease/psychology , Genetic Testing , Humans , Middle Aged , Ovarian Neoplasms/psychology
8.
Patient Educ Couns ; 101(7): 1157-1174, 2018 07.
Article in English | MEDLINE | ID: mdl-29455939

ABSTRACT

OBJECTIVE: We conducted a systematic review to identify the strategies that have been recommended in the literature to facilitate shared decision-making regarding enrolment in pediatric oncology clinical trials. METHODS: We searched seven databases for peer-reviewed literature, published 1990-2017. Of 924 articles identified, 17 studies were eligible for the review. We assessed study quality using the 'Mixed-Methods Appraisal Tool'. We coded the results and discussions of papers line-by-line using nVivo software. We categorized strategies thematically. RESULTS: Five main themes emerged: 1) decision-making as a process, 2) individuality of the process; 3) information provision, 4) the role of communication, or 5) decision and psychosocial support. Families should have adequate time to make a decision. HCPs should elicit parents' and patients' preferences for level of information and decision involvement. Information should be clear and provided in multiple modalities. Articles also recommended providing training for healthcare professionals and access to psychosocial support for families. CONCLUSION: High quality, individually-tailored information, open communication and psychosocial support appear vital in supporting decision-making regarding enrollment in clinical trials. These data will usefully inform future decision-making interventions/tools to support families making clinical trial decisions. PRACTICE IMPLICATIONS: A solid evidence-base for effective strategies which facilitate shared decision-making is needed.


Subject(s)
Clinical Trials as Topic , Communication , Decision Making , Medical Oncology , Parents , Patient Selection , Pediatrics , Child , Humans , Infant , Neoplasms/therapy
9.
Psychooncology ; 27(6): 1524-1529, 2018 06.
Article in English | MEDLINE | ID: mdl-29476578

ABSTRACT

OBJECTIVE: Young women with unilateral breast cancer are increasingly choosing contralateral prophylactic mastectomy (CPM), despite its limited medical benefit for most women. The purpose of this study was to better understand this choice through a qualitative exploration of surgical decision-making in young survivors, including how issues particular to younger women affected their decision and the post-surgical experience. METHODS: Women age ≤ 40 years with stage 0 to III breast cancer, 1 to 3 years from diagnosis who had undergone breast cancer surgery were recruited to participate. Four focus groups were conducted: 2 with women who had bilateral mastectomy and 2 with women who kept their contralateral breast. Focus groups were recorded and transcribed with identifiers removed. Emergent themes were identified by thematic content analysis using NVivo 11. RESULTS: Of the 20 participants, median age at diagnosis was 37 years. Emergent themes were categorized into the following domains: (1) emotions/feelings surrounding surgery/decision about surgery; (2) factors affecting the decision; (3) communication and interaction with the healthcare team; (4) impact on post-surgical life and recovery; and (5) support needs. Young women who chose CPM often were concerned about a future breast event, despite this low risk, suggesting some gain peace of mind by choosing CPM. Young survivors also had many physical and emotional concerns after surgery for which they did not always feel prepared. CONCLUSIONS: Informational resources and decision aids may enhance patient-doctor communication and help young survivors better understand risk and manage expectations surrounding short and longer-term physical and emotional effects after surgery.


Subject(s)
Breast Neoplasms/psychology , Breast Neoplasms/surgery , Cancer Survivors/psychology , Mastectomy/psychology , Adult , Decision Making , Female , Humans
10.
Pediatr Blood Cancer ; 65(4)2018 04.
Article in English | MEDLINE | ID: mdl-29286558

ABSTRACT

BACKGROUND: There is growing impetus for increased genetic screening in childhood cancer survivors. Family history-taking is a critical first step in determining survivors' suitability. However, the family history-taking practices of providers of pediatric oncology survivorship care and the confidence of these providers to discuss cancer risks to relatives are unknown. PROCEDURE: Fifty-four providers completed semistructured interviews in total, which included eight tertiary providers representing nine hospitals across two countries (63% male, 63% oncologists, 37% nurses) and 46 primary care providers (PCPs) nominated by a survivor (59% male, 35% regional practice). We used content analysis and descriptive statistics/regression to analyze the data. RESULTS: Few tertiary (38%) or primary (35%) providers regularly collected survivors' family histories, often relying on survivors/parents to initiate discussions. Providers mostly took two-generation pedigrees (63% tertiary and 81% primary). Primary providers focused on adult cancers. Lack of time, alternative priorities, and perceived lack of relevance were common barriers. Half of all tertiary providers felt moderately comfortable discussing genetic cancer risk to children of survivors (88% felt similarly discussing risks to other relatives). Most primary providers lacked confidence: 41% felt confident regarding risks to survivors' children and 48% regarding risks to other relatives. CONCLUSIONS: While family history-taking will not identify all survivors suitable for genetics assessment, recommendations for regular history-taking are not being implemented in tertiary or primary care. Additional PCP-targeted genetic education is warranted given that they are well placed to review family histories of pediatric cancer survivors.


Subject(s)
Cancer Survivors , Genetic Counseling , Genetic Testing , Health Personnel , Medical History Taking , Adolescent , Adult , Child , Female , Humans , Male , Pilot Projects , Risk Factors
11.
J Genet Couns ; 26(6): 1179-1196, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28667568

ABSTRACT

Understanding challenges in familial communication of cancer risk has informed genetic service delivery. Parent-child interactions have received considerable attention, but few studies focus on young adulthood experiences within BRCA1/2 families. Young adults are approaching, or at a life stage where awareness of hereditary cancer risk is vital for informed choice of risk management options. This review assesses family communication, risk perception and cancer knowledge held by 18-40 year old individuals who have a parent with a BRCA1/2 gene mutation or carry the gene mutation themselves. Thirteen papers met the inclusion criteria. One utilized a 'mixed methods' methodology and the remaining used a qualitative approach. Findings were synthesized into themes and reported narratively. In general, parents are communicating openly about genetic risk with young adult offspring, but there is evidence that some young adults are withholding information from their parents about their own test results. Risk perception is influenced by a family history of cancer, childbearing plans and health providers' advice. Misconceptions about genetic risk appear to be common and gaps in hereditary cancer knowledge are evident. It is unclear whether incorrect knowledge was passed from parents to offspring. Health providers need to provide developmentally appropriate services for emerging adults (18-25 years old), with particular support in navigating through risk management options.


Subject(s)
Adult Children , Genes, BRCA1 , Genes, BRCA2 , Neoplasms/genetics , Parent-Child Relations , Adult , Female , Genetic Predisposition to Disease , Humans , Male , Mutation , Neoplasms/prevention & control , Young Adult
12.
J Genet Couns ; 26(2): 251-260, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27699628

ABSTRACT

The defining difference between genetic and traditional medicine is that genetic findings have implications not just for the patient, but also for their relatives. Discussion of a test result between parent and child is both a transformative and a translational moment in the life of a family. Parents report wanting help in talking to their children. The challenge for genetic counselors and other providers is to be able to recognize which issues are at the core of parental distress and be able to offer recommendations to empower and support parents. The complexity of potential genetic findings, including variants of uncertain significance (VUS) and incidental findings have vastly increased, requiring considerable explanation and leaving less time for discussion of emotional issues. While the nature of the testing (single gene to multigene panel and genomic testing) is dramatically changing, the nature of parent concerns remains remarkably constant. Families differ in many respects, so no "recipe" suffices to answer parents' questions about how this important task should be approached in each family. Successful consultation to parents requires true counseling, matching parents' fears and questions with information, exploration and advice specific to their concerns, their circumstances and strengths.


Subject(s)
Genetic Counseling/psychology , Neoplasms/diagnosis , Neoplasms/psychology , Parents/psychology , Adolescent , Adult , Child , Female , Genetic Testing , Humans , Incidental Findings , Neoplasms/genetics , Psychology, Applied , Young Adult
13.
Psychooncology ; 26(4): 563-569, 2017 04.
Article in English | MEDLINE | ID: mdl-27530206

ABSTRACT

The International Psycho-Oncology Society (IPOS) Human Rights Task Force has been working since 2008 to raise awareness and support, for the relevance of psychosocial cancer care as a human rights issue. In 2014 the "Lisbon Declaration: Psychosocial Cancer Care as a Universal Human Right" was fully endorsed by IPOS. Subsequently, the IPOS Standard on Quality Cancer Care, endorsed by 75 cancer organizations worldwide, has been updated and now includes 3 core principles: Psychosocial cancer care should be recognised as a universal human right; Quality cancer care must integrate the psychosocial domain into routine care; Distress should be measured as the 6th vital sign. The President's plenary held at the 2015 World Congress of Psycho-Oncology in Washington DC was devoted to discussing psychosocial care as a human rights issue. Many challenges and opportunities are illustrated in different continents and contexts: from Africa where resources for basic cancer treatment are scarce and children and their parents face significant difficulties with hospital detention practices; to Europe where for many countries psychosocial care is still seen as a luxury; and the Middle East where Muslim women face stigma and a culture of silence over cancer. We further discuss how to move the Lisbon Declaration forward towards its implementation into clinical practice globally, using the successful example of the World Health Assembly resolution supporting palliative care as a human right which has achieved widespread approval, and identifying the vital role the IPOS Federation of National Psychoncology Societies plays worldwide to move this agenda forward.


Subject(s)
Medical Oncology/organization & administration , Neoplasms/psychology , Neoplasms/therapy , Psychotherapy/standards , Child , Congresses as Topic , Cooperative Behavior , Humans , Interdisciplinary Communication , Interprofessional Relations , Psycho-Oncology/organization & administration , Societies, Medical/standards
14.
J Psychosoc Oncol ; 34(6): 493-511, 2016.
Article in English | MEDLINE | ID: mdl-27541834

ABSTRACT

Survivors of pediatric brain tumors experience several medical and psychosocial late effects including deficits in social competence. This mixed methods study investigated the experience of 19 adolescent and young adult survivors of pediatric brain tumors and 17 parents who participated in a social support program. Qualitative results demonstrated a significant social isolation that was compounded by medical late effects. Survivors perceived social support and acceptance from interactions with peers who have similar medical backgrounds as a key aspect of the group experience. Parents reported increased social confidence among survivors, although they did not report that social gains generalized beyond the group setting. Interventions to promote the transfer of specific social skills are needed.


Subject(s)
Brain Neoplasms/psychology , Interpersonal Relations , Peer Group , Social Support , Survivors/psychology , Adolescent , Adult , Brain Neoplasms/therapy , Female , Humans , Male , Parents/psychology , Program Evaluation , Qualitative Research , Social Skills , Survivors/statistics & numerical data , Young Adult
15.
J Dev Behav Pediatr ; 37(6): 475-82, 2016.
Article in English | MEDLINE | ID: mdl-27355881

ABSTRACT

OBJECTIVE: Evaluate the acceptability, feasibility, and preliminary outcomes of a peer-mediated intervention to improve social competence of brain tumor survivors and classmates. METHOD: Twelve childhood brain tumor survivors and 217 classroom peers in intervention (n = 8) or comparison (n = 4) classrooms completed measures of social acceptance and reputation at 2 time points in the year. The intervention (5-8 sessions over 4-6 weeks) taught peer leaders skills for engaging classmates. Individual and classroom outcomes were analyzed with analysis of covariance. RESULTS: Recruitment rates of families of brain tumor survivors (81%) and schools (100%) were adequate. Peer leaders reported satisfaction with the intervention. Preliminary outcome data trended toward some benefit in increasing the number of friend nominations for survivors of brain tumors but no changes in other peer-reported metrics. Preliminary results also suggested some positive effects on classroom levels of victimization and rejection. CONCLUSION: A peer-mediated intervention was acceptable to families of brain tumor survivors and feasible to implement in schools. Findings warrant a larger trial to evaluate improvements for children with brain tumors and their peers.


Subject(s)
Brain Neoplasms/psychology , Cancer Survivors/psychology , Peer Group , Social Skills , Socioenvironmental Therapy , Adolescent , Child , Feasibility Studies , Female , Humans , Leadership , Male , Patient Acceptance of Health Care
16.
Cancer ; 122(18): 2876-85, 2016 09 15.
Article in English | MEDLINE | ID: mdl-27258553

ABSTRACT

BACKGROUND: Genetic testing to determine cancer survivors' risk of developing late effects from their cancer treatment will be increasingly used in survivorship care. This 2-stage study with 64 survivors of childhood cancer and their parents investigated the preferences and acceptability of testing among those who may be at risk of developing late effects. METHODS: The first stage (Stage 1) identified the most commonly perceived benefits and concerns regarding genetic testing for the risk of late effects among 24 participants. In Stage 2, during interviews, 20 survivors (55% of whom were female; mean age, 26.0 years [range, 18-39 years]; standard deviation [SD], 0.80) and 20 parents (55% of whom were male; mean age of child survivor, 14.2 years [range, 10-19 years]; SD, 0.79) rated the 7 most common benefits and concerns from those identified in Stage 1. Interviews were transcribed verbatim and analyzed. Decisional balance ratios were calculated by dividing the participants' average concerns scores with the average benefits scores. RESULTS: Genetic testing for late effects was highly acceptable: 95% of participants leaned toward testing, and the majority (65.9%) would pay up to Australian $5000. The majority (97.2%) reported it was acceptable to wait for up to 6 months to receive results, and to be offered testing immediately after treatment or when the survivor reached adulthood (62.9%). Survivors and parents had a highly positive decisional balance (Mean (M), 0.5 [SD, 0.38] and M, 0.5 [SD, 0.39], respectively), indicating that perceived benefits outweighed concerns. CONCLUSIONS: Although to our knowledge clinical efficacy has yet to be clearly demonstrated, survivors and parents described positive interest in genetic testing for the risk of developing late effects. Perceived benefits outweighed harms, and the majority of participants would be willing to pay, and wait, for testing. Cancer 2016. © 2016 American Cancer Society. Cancer 2016;122:2876-2885. © 2016 American Cancer Society.


Subject(s)
Genetic Testing/economics , Genetic Testing/methods , Health Knowledge, Attitudes, Practice , Neoplasms/economics , Neoplasms/genetics , Adolescent , Adult , Female , Genetic Predisposition to Disease , Humans , Male , Neoplasms/mortality , Neoplasms/psychology , Patient Acceptance of Health Care , Risk , Survivors , Young Adult
18.
Genet Med ; 18(8): 755-62, 2016 08.
Article in English | MEDLINE | ID: mdl-26741411

ABSTRACT

PURPOSE: This review assessed the psychological impact that acquiring personal and familial genetic information has on children. We also examined the concordance between the available empirical data and clinical guidance/perspectives articles. METHODS: We screened 591 abstracts and identified 13 studies, representing 966 children. Ten studies assessed 386 children tested for familial adenomatous polyposis (n = 171), hereditary cardiac disease (n = 134), and other conditions (n = 81). Three studies addressed the impact of BRCA1/2 testing of a family member on 580 children. RESULTS: Serious adverse psychological outcomes were uncommon. Most studies reported no significant increase in mean anxiety, depression, and distress scores (n = 8, 61.5%); however, some children experienced intrafamilial distress, discrimination, and guilt/regret. Some children were more concerned about their own health or their family members' health. There was limited consistency between anticipated adverse impact and empirical data. CONCLUSIONS: The review identified little conclusive evidence of deleterious psychological consequences for children acquiring genetic information. However, there is a lack of data regarding genetic testing for conditions that may not be treatable/modifiable, as well as a dearth of longitudinal studies. Therefore, clinical caution remains essential for the ethical integration of genetic testing into pediatrics. Further research assessing the potential positive and negative effects of genetic testing in childhood is warranted.Genet Med 18 8, 755-762.


Subject(s)
Child Behavior/psychology , Stress, Psychological/etiology , Adolescent , Child , Female , Genetic Testing , Humans , Male
19.
Pediatr Blood Cancer ; 63(2): 191-5, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26451963

ABSTRACT

As the mortality of pediatric cancers has decreased, focus on neuropsychological morbidities of treatment sequelae have increased. Neuropsychological evaluations are essential diagnostic tools that assess cognitive functioning and neurobiological integrity. These tests provide vital information to support ongoing medical care, documenting cognitive morbidity and response to interventions. We frame standards for neuropsychological monitoring of pediatric patients with CNS malignancy or who received cancer-directed therapies involving the CNS and discuss billing for these services in the United States in the context of clinical research. We describe a cost-effective, efficient model of neuropsychological monitoring that may increases access to neuropsychological care.


Subject(s)
Central Nervous System Neoplasms/psychology , Medical Oncology/standards , Neurology/standards , Neuropsychological Tests/standards , Pediatrics/standards , Central Nervous System Neoplasms/therapy , Child , Humans , Medical Oncology/economics , Neurology/economics , Pediatrics/economics , Standard of Care , Survivors/psychology , United States
20.
Palliat Support Care ; 14(1): 33-41, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26653250

ABSTRACT

OBJECTIVE: Burnout is reportedly high among oncology healthcare workers. Psychosocial oncologists may be particularly vulnerable to burnout. However, their work engagement may also be high, counteracting stress in the workplace. This study aimed to document the prevalence of both burnout and work engagement, and the predictors of both, utilizing the job demands-resources (JD-R) model, within a sample of psychosocial oncologists. METHOD: Psychosocial-oncologist (N = 417) clinicians, recruited through 10 international and national psychosocial-oncology societies, completed an online questionnaire. Measures included demographic and work characteristics, burnout (the MBI-HSS Emotional Exhaustion (EE) and Depersonalization (DP) subscales), the Utrecht Work Engagement Scale, and measures of job demands and resources. RESULTS: High EE and DP was reported by 20.2 and 6.6% of participants, respectively, while 95.3% reported average to high work engagement. Lower levels of job resources and higher levels of job demands predicted greater burnout, as predicted by the JD-R model, but the predicted interaction between these characteristics and burnout was not significant. Higher levels of job resources predicted higher levels of work engagement. SIGNIFICANCE OF RESULTS: Burnout was surprisingly low and work engagement high in this sample. Nonetheless, one in five psychosocial oncologists have high EE. Our results suggest that both the positive (resources) and negative (demands) aspects of this work environment have an on impact burnout and engagement, offering opportunities for intervention. Theories such as the JD-R model can be useful in guiding research in this area.


Subject(s)
Burnout, Professional/psychology , Health Personnel/psychology , Stress, Psychological/psychology , Workplace/psychology , Adult , Aged , Depersonalization/psychology , Fatigue/etiology , Fatigue/psychology , Female , Humans , Male , Medical Oncology , Middle Aged , Prevalence , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...